Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The tight supply of both beans meant trading prices were extremely volatile, and the result was that cocoa almost tripled in price last year.
Owning a Rolls-Royce is pretty good. But is it really that impressive when you could have a unique Rolls-Royce?
Novo Nordisk on Wednesday announced an expanded deal with healthtech firm Valo Health to use AI to fuel drug discovery.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
According to the Financial Times, Apple is ramping up its Apple News division. But can it fix its irritating AI hallucinations?
Alico, a major supplier to Tropicana, announced Monday that it is sunsetting its citrus business in the Sunshine State.
The deal puts an end to Fubo’s ongoing lawsuit that sought to block Disney’s efforts to build Venu Sports with Fox and Warner Bros. Discovery.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
In a 2023 Gallup survey, 62% of American adults under 35 said they drink alcohol, down from 72% twenty years earlier.
The odds of an increase in regulation of the massive, and growing, sports-betting industry may be shifting.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.